By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyse site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Latest research:
Type 2 diabetes

F Quarti-Trevano et al, Chronic coffee consumption and diabetogenic risk: data from the PAMELA study, Nutrition, Metabolism and Cardiovascular Disease.

Chronic coffee consumption and diabetogenic risk: data from the PAMELA study

F Quarti-Trevano
Nutrition Metabolism and Cardiovascular Disease
September 24, 2026

ABSTRACT

Background and aim:
The present study was designed to investigate a controversial issue, namely whether and to what extent chronic coffee consumption is associated with an increased diabetogenic risk.

Methods and results:
We examined data collected cross-sectionally and prospectively in 1158 healthy subjects belonging to the general population of the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study. Results collected at the cross-sectional examination performed at baseline show fasting serum glucose (89.4 ± 12.6 vs 89.9 ± 20.9 mg/dl, means ± SD, PNS) and incidence of impaired fasting glucose (IFG, 8.1%vs 5.5%, PNS) superimposable in coffee consumers (≥2-3 cups of coffee per day) and non-consumers. This was the case also when incidence of diabetes mellitus and use of antidiabetic drug treatment were examined. Furthermore, data collected at the 10-years follow-up examination show that the risk of new IFG and new diabetes mellitus was similar in coffee consumers and non-consumers.

Conclusions:
The results of the present PAMELA study suggest that in our general population chronic consumption of coffee has a neutral long-term impact on glucose metabolism.

More research

All research